Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: March

Request Number: A-2022-001311

Request Summary: Adverse Drug Reactions (ADRs) for REXULTI, ARIPIPRAZOLE. Report numbers: E2B_05795715, E2B_05717142, E2B_05720816. ADR for REXULTI. Report number: E2B_05723433. ADRs for ABILIFY MAINTENA, ARIPIPRAZOLE. Report numbers: E2B_05724504, E2B_05717118.

Disposition: All disclosed

Number of pages: 139

Date modified: